| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/05/2004 | US20040023335 IL-17 like molecules and uses thereof |
| 02/05/2004 | US20040023334 Comprises lactoferrin fusion protein for diagnosis, prevention treatment and prognosis of nervous system, respiratory, cardiovascular and/or reproductive system disorders |
| 02/05/2004 | US20040023333 Production of recombinant blood clotting factors in human cell lines |
| 02/05/2004 | US20040023328 Comprises peptide sequences associatead with potassium channel proteins for diagnosing and treating tumors and vessicle transport disorders |
| 02/05/2004 | US20040023322 Preparing bone morphogenic proteins (BMP) in mammalian culture for use in models of bone formation |
| 02/05/2004 | US20040023314 Identifying cells that will differentiate into metastatic cancer via presence of increased concentration of aberrant cell adhesion molecule and decrease in cellular matrix formation |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | US20040023291 Comprises insect polypeptide for use in hemolysis and immunosuppression; immunotherapy |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040023278 Sialoadhesin family member-2 (SAF-2) |
| 02/05/2004 | US20040023267 Comprises nucleotide sequences coding cancer associated proteins (CAP) for diagnosis, prevention and treatment of tumors |
| 02/05/2004 | US20040023260 29 human secreted proteins |
| 02/05/2004 | US20040023259 Comprises proteins for treating and preventing cell proliferation disorders; antitumor agents |
| 02/05/2004 | US20040023257 Comprises nucleotide sequences coding proteolytic enzymes for increasing flavor in food, promoting microbiocidal activity, modifying and deprotecting chemical intermediates, synthesis and hydrolysis of cephalosporins |
| 02/05/2004 | US20040023252 G-protein coupled receptors |
| 02/05/2004 | US20040023243 Proteases |
| 02/05/2004 | US20040023227 Functions as a control in the activity of squalene epoxidase, which is the rate-limiting enzyme in the cholesterol biosynthesis |
| 02/05/2004 | US20040023219 Novel prostate cancer genes |
| 02/05/2004 | US20040023215 Methods and compositions employing the nucleic acids, polypeptides or peptides, antibodies, and/or ligands for use in diagnostics and therapeutics for asthma and other diseases |
| 02/05/2004 | US20040023205 Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material |
| 02/05/2004 | US20040023204 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/05/2004 | US20040022873 Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as anthrax, smallpox or radiation and for vaccination prophylaxis, and use in combination with DHEA for the treatment of smallpox and other viruses |
| 02/05/2004 | US20040022870 Immunogenic TLP composition |
| 02/05/2004 | US20040022869 Containing microtubule stabilizing agents and one or more heat shock protein (HSP)-inducing agents; treating a proliferative disorder, an infectious disease, a cardiovascular disease, an autoimmune disorder, or an inflammatory disorder |
| 02/05/2004 | US20040022858 Reverse phase connective tissue repair composition |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040022838 Regulation of cell proliferation and differentiation using topically applied peptides |
| 02/05/2004 | US20040022807 Methods for treating obesity |
| 02/05/2004 | US20040022804 Administering protein Q or a variant thereof containing modifications or substitutions of preserved amino acid residues, protein Q or variant thereof being optionally combined with complete or fragmented protein LiHsp70 and |
| 02/05/2004 | US20040022799 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 02/05/2004 | US20040022797 Eta-1 gene and methods for use |
| 02/05/2004 | US20040022790 CNS neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/05/2004 | US20040022788 Compositions and methods for promoting or inhibiting angiogenesis |
| 02/05/2004 | US20040022787 Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
| 02/05/2004 | US20040022785 Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth |
| 02/05/2004 | US20040022783 Binding agents to CD23 |
| 02/05/2004 | US20040022782 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022780 Topically applying to the skin of a mammal an effective amount of topically active formulation comprising a first topically active agent for therapy |
| 02/05/2004 | US20040022779 Method for identifying apoptosis-modified proteins |
| 02/05/2004 | US20040022777 Fragments and antagonists of heat shock protein 60 |
| 02/05/2004 | US20040022774 Fibrocyte-based vaccine formulations |
| 02/05/2004 | US20040022772 Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth |
| 02/05/2004 | US20040022768 Process useful for producing selective immune down regulation (SIDR) in subjects, including adult subjects to artificially expressed gene, gene delivery systems, infectious agents, and non-cellular immunogenic components, and processes for producing immunological tolerance in subjets using SIDR |
| 02/05/2004 | US20040022767 Novel cytokine designated elk ligand |
| 02/05/2004 | US20040022766 Administering by subretinal injection an effective amount of recombinant adeno-associated virus carrying a nucleic acid sequence encoding normal gene under the control of promoter sequence which expresses the product of gene in ocular cells |
| 02/05/2004 | US20040022765 For cancer therapy |
| 02/05/2004 | US20040022763 Human recombinant beta-interferon with improved solubility |
| 02/05/2004 | US20040022762 Use of il-8 protein modulators in the treatment of viral infections |
| 02/05/2004 | US20040022760 Administering Flt3-ligand to a subject; optionally administering an auxiliary molecule; administering a vaccine to the subject, wherein the vaccine comprises an antigen and an adjuvant |
| 02/05/2004 | US20040022758 Hair tonics and method of screening the same |
| 02/05/2004 | US20040022739 Nasal spray formulation and method |
| 02/05/2004 | US20040022727 For therapy of proliferative diseases |
| 02/05/2004 | DE10232697A1 Verwendung von CD152 zur Behandlung von Autoimmunkrankheiten und Entzündungen Use of CD152 for the treatment of autoimmune diseases and inflammations |
| 02/05/2004 | DE10158036A1 Antiallergic pharmaceutical compositions, useful e.g. for treating allergic rhinitis or asthma, containing lactalbumin hydrolyzate (or its fraction) to improve effectiveness and reduce dose of active agent |
| 02/05/2004 | CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2494098A1 Methods of using non-human animal apoliprotein a-i protein |
| 02/05/2004 | CA2493949A1 Modified small interfering rna molecules and methods of use |
| 02/05/2004 | CA2493798A1 Improved systems and methods for analysis of protein post-translational modification |
| 02/05/2004 | CA2493581A1 Ophthalmologic irrigation solutions and method |
| 02/05/2004 | CA2493306A1 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | CA2493172A1 Method of treating tumors |
| 02/05/2004 | CA2492542A1 Oligodendrocyte production from multipotent neural stem cells |
| 02/05/2004 | CA2492463A1 Regulated aptamer therapeutics |
| 02/05/2004 | CA2492442A1 Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
| 02/05/2004 | CA2492434A1 Method of enhancing and/or inducing neuronal migration using erythropoietin |
| 02/05/2004 | CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2492295A1 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 02/05/2004 | CA2488863A1 Identification of a novel bitter taste receptor, t2r76 |
| 02/05/2004 | CA2488348A1 Long lasting natriuretic peptide derivatives |
| 02/05/2004 | CA2486795A1 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 02/05/2004 | CA2486714A1 Compositions for penis enlargement |
| 02/05/2004 | CA2484941A1 Antigens encoded by alternative reading frame from pathogenic viruses |
| 02/04/2004 | EP1386933A1 Cytokine antagonists and agonists |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386931A1 Human neurotrimin homologue |
| 02/04/2004 | EP1386930A1 Derivatives of exendin |
| 02/04/2004 | EP1386929A1 Peptides associated with tumors and uses related thereto |
| 02/04/2004 | EP1386928A1 A frog skin antibacterial peptide derivative |
| 02/04/2004 | EP1386927A1 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
| 02/04/2004 | EP1386639A1 Use of 78 genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1386616A1 Antibordetella vaccine |
| 02/04/2004 | EP1386615A1 EG-VEGF/Prokineticin 2 receptor antagonists |
| 02/04/2004 | EP1386165A2 Inflammatory markers for detection and prevention of diabetes mellitus |
| 02/04/2004 | EP1386162A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/04/2004 | EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
| 02/04/2004 | EP1386007A2 Skin treatment |
| 02/04/2004 | EP1386004A2 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies |
| 02/04/2004 | EP1385989A2 Il-1 inhibition for myeloma and related disorders |
| 02/04/2004 | EP1385987A2 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385966A2 Recombinant fusion proteins and the trimers thereof |
| 02/04/2004 | EP1385962A2 Human prolyl 4-hydroxylases |
| 02/04/2004 | EP1385959A2 Method of producing recombinant antibodies against tumours |
| 02/04/2004 | EP1385958A2 Human tachykinin-related splice variants and compositions thereof |
| 02/04/2004 | EP1385957A1 Functions for d52 and ra006 nucleic acids and polypeptides |
| 02/04/2004 | EP1385955A2 Cell adhesion proteins |
| 02/04/2004 | EP1385954A2 Proteins associated with cell growth, differentiation, and death |
| 02/04/2004 | EP1385953A2 Proteins and nucleic acids encoding same |